The standard recommendation for young children with autism receiving ABA therapy has long been 25 to 40 hours per week of direct intervention. This figure has shaped clinical guidelines, insurance authorization criteria, and provider recommendations for decades. For many families, it determines how many hours they fight for with their insurance company and how they evaluate the adequacy of a proposed program.
In 2024, a meta-analysis published in JAMA Pediatrics challenged that assumption directly. The study concluded that higher treatment intensity did not consistently predict better outcomes for young autistic children. The finding generated significant controversy within the ABA field — and significant confusion among families trying to understand what it means for their child's treatment.
What the 2024 meta-analysis actually said
The Sandbank et al. 2024 meta-analysis, published in JAMA Pediatrics, analyzed data from 96 studies examining intervention amount and outcomes for young autistic children. The study concluded that it could not establish a consistent association between the number of therapy hours per week and the magnitude of outcomes across cognitive, language, adaptive, and social domains.
The finding was widely reported in general media as suggesting that "more ABA isn't better" — a headline that traveled far outside the clinical literature and reached families, insurance reviewers, and policymakers. This is the version of the finding most people encountered. It is not an accurate characterization of what the research showed or what its limitations were.
To its credit, the Sandbank study was not a dismissal of ABA as an intervention. It was a methodological analysis of how intensity was measured and reported across studies. The conclusions it drew, however, were disputed by multiple professional organizations and researchers who identified fundamental problems with the study's design.
Why the ABA field rejected the conclusions
The Council of Autism Service Providers published a detailed white paper in early 2025 — Evidence About ABA Treatment for Young Children with Autism — specifically responding to the Sandbank findings and another similarly disputed study by Ostrovsky et al. 2023. The CASP critique identified a methodological problem that fundamentally limits the conclusions the 2024 meta-analysis could support.
The core issue is scope of treatment. Comprehensive ABA addresses multiple developmental domains simultaneously — language, communication, self-care, play, social skills, academic readiness — and typically requires 25 to 40 hours per week because there is a large amount of clinical ground to cover. Focused ABA targets a specific behavior or skill — reducing a single challenging behavior, teaching one functional communication skill — and may require far fewer hours. These are not the same intervention at different dosages. They are different types of treatment with different clinical goals.
The Sandbank study included both comprehensive and focused intervention studies in the same analysis without adequately controlling for this distinction. Comparing their hours and outcomes as if they were equivalent is, as CASP described it, like measuring whether medication dose predicts outcomes without distinguishing between different medications. The variable of interest — intensity — cannot be meaningfully analyzed without controlling for what the intensive hours are actually delivering. Subsequent critique by Frazier et al. 2025 reached similar conclusions about the study's methodological limitations.
What controlled analyses actually found
Eldevik et al. 2024 conducted a more controlled analysis of 341 children receiving comprehensive ABA treatment, specifically examining the effect of treatment intensity while controlling for the scope of what was being delivered. The findings were substantially different from what Sandbank reported.
When children receiving the same type of comprehensive ABA were compared at different intensity levels, intensity was a significant predictor of outcomes. Children receiving comprehensive intervention at 30 or more hours per week showed greater improvements on standardized measures — larger change scores and a higher percentage of children moving into the non-clinical range on post-intervention assessments — compared to children receiving the same comprehensive program at lower intensity.
This is consistent with the broader body of longitudinal early intervention research. The Lovaas 1987 study — the foundational study in intensive ABA for autism — specifically examined comprehensive early intervention at 40 hours per week. The replications, meta-analyses, and long-term follow-up studies that followed have consistently shown that comprehensive intervention intensity matters, particularly when it begins early and maintains fidelity over time.
The distinction between comprehensive and focused treatment
This distinction is not academic — it is clinically essential for families evaluating their child's program. A child who is newly diagnosed at 18 months with absent functional communication, limited social engagement, and behavioral rigidity across multiple domains is a candidate for comprehensive early intervention. The goal is to address the entire developmental landscape, not a single target. That program warrants the higher intensity reflected in CASP's 2024 clinical guidelines, which recommend 10 to 40 hours per week depending on the type and scope of the intervention.
A nine-year-old with autism spectrum disorder who is functioning academically in an inclusive classroom but has a specific behavioral challenge — aggression in particular contexts, difficulty with transitions, a single communication skill deficit — is a different clinical profile. A focused, lower-intensity intervention targeting that specific area may be entirely appropriate. Prescribing 40 hours per week of comprehensive treatment for this child would be clinically inappropriate regardless of what any guideline says.
The mismatch the Sandbank study inadvertently exposed is real: some children in ABA programs are receiving higher intensity than their current clinical needs require, and some are receiving lower intensity than their comprehensive program demands. The solution is not to abandon intensity recommendations — it is to ensure that the scope of the program and the intensity of delivery are clinically matched.
What this means for your child's program
The practical implication for families is that "hours per week" is not the right question to start with. The right questions are: what is the scope of my child's program? Is it comprehensive or focused? Is the recommended intensity calibrated to what the program is trying to accomplish? And how will progress at this intensity level be measured and reassessed?
For young children receiving comprehensive early intensive behavioral intervention, the evidence-supported intensity recommendation from CASP's 2024 clinical guidelines — 25 to 40 hours per week — remains the appropriate benchmark. Insurers who cite the Sandbank study to justify reducing authorized hours for young children in comprehensive programs are misapplying research to reach a predetermined conclusion. Families whose hours are being reduced on these grounds should ask their BCBA to respond in writing with the relevant clinical literature.
Intensity without fidelity is not a substitute for a well-supervised program at appropriate hours. A poorly implemented 40-hour program will underperform a rigorously supervised 25-hour program. Both the hours and the quality of what fills those hours matter. Evaluating only one without the other is an incomplete analysis of whether a child's program is adequate.
Questions to ask your child's BCBA
Based on the research above, these are the questions that should drive your next conversation about your child's program: Is my child's ABA program classified as comprehensive or focused — and what does that mean for the recommended intensity? What specific domains is the program addressing, and how were those domains selected? How will we measure whether the current intensity level is producing adequate progress? Under what conditions would you recommend increasing or decreasing hours?
A BCBA who can answer these questions specifically and clearly is a BCBA who has matched their clinical reasoning to the evidence. Vague answers about "what insurance will authorize" or appeals to a single number without reference to your child's specific clinical profile are signals worth probing.
